Prekallikrein deficiency is a disorder that often remains undiagnosed. Prekallikrein activates factor XII, which initiates the intrinsic coagulation pathway. Prekallikrein deficiency results in prolonged Partial Thromboplastin Time and Activated Clotting Time in absence of anticoagulants or active bleeding. This case report describes the anesthesia management of a patient with Prekallikrein deficiency who underwent cardiac surgery with Cardiopulmonary Bypass for correction of a congenital cardiac malformation. We highlight the importance of understanding the different tests available for the diagnosis of coagulation factors deficiency during administration of heparin in the setting of cardiovascular procedures under general anesthesia.
References
[1]
Bolliger, D., Maurer, M. and Tanaka, K.A. (2020) Toward Optimal Anticoagulation Monitoring during Cardiopulmonary Bypass: It Is Still a Tough “ACT”. Journal of Cardiothoracic and Vascular Anesthesia, 34, 2928-2930. https://doi.org/10.1053/j.jvca.2020.07.024
[2]
Chen, Y., Phoon, P.H.Y. and Hwang, N.C. (2022) Heparin Resistance during Cardiopulmonary Bypass in Adult Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia, 36, 4150-4160. https://doi.org/10.1053/j.jvca.2022.06.021
Yasin, H., Jamil, M.O. and Williams Iii, L.A. (2020) Diagnostic Pearls and Clinical Implications of Prekallikrein Deficiency. Cureus, 12, e8349. https://doi.org/10.7759/cureus.8349
[5]
Girolami, A., et al. (2020) Long-Term Safety Outcomes of Prekallikrein (Fletcher Factor) Deficiency: A Systematic Literature Review of Case Reports. Allergy and Asthma Proceedings, 41, 10-18. https://doi.org/10.2500/aap.2020.41.190005
[6]
Girolami, A., et al. (2010) Congenital Prekallikrein Deficiency. Expert Review of Hematology, 3, 685-695. https://doi.org/10.1586/ehm.10.69
[7]
Willems, A., et al. (2016) Heparin Reversal after Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable? Journal of Cardiothoracic and Vascular Anesthesia, 30, 1184-1189. https://doi.org/10.1053/j.jvca.2016.03.004
[8]
Winter, W.E., Flax, S.D. and Harris, N.S. (2017) Coagulation Testing in the Core Laboratory.Laboratory Medicine, 48, 295-313. https://doi.org/10.1093/labmed/lmx050
[9]
Despotis, G.J. and Joist, J.H. (1999) Anticoagulation and Anticoagulation Reversal with Cardiac Surgery Involving Cardiopulmonary Bypass: An Update. Journal of Cardiothoracic and Vascular Anesthesia, 13, 18-29. https://doi.org/10.1016/S1053-0770(21)00594-2
[10]
Dyer, J.R. and Raj, T. (2006) Prolonged Activated Partial Thromboplastin Time in Patients with Antiphospholipid Antibody Syndrome. Anesthesia & Analgesia, 103, 1586-1587. https://doi.org/10.1213/01.ane.0000246350.35872.0b
[11]
Newall, F. (2013) Anti-Factor Xa (Anti-Xa) Assay. In: Monagle, P., Ed., Haemostasis, Vol. 992, Humana Press, Totowa, NJ, 265-272. https://doi.org/10.1007/978-1-62703-339-8_19